Clinical Trial Update: A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

The document reports the completion of a long-term extension Phase 2 trial evaluating Janssen's investigational therapy JNJ-77242113 in adults with moderate-to-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED